These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 11704870

  • 1. Glypican-3 expression is silenced in human breast cancer.
    Xiang YY, Ladeda V, Filmus J.
    Oncogene; 2001 Nov 01; 20(50):7408-12. PubMed ID: 11704870
    [Abstract] [Full Text] [Related]

  • 2. Frequent silencing of the GPC3 gene in ovarian cancer cell lines.
    Lin H, Huber R, Schlessinger D, Morin PJ.
    Cancer Res; 1999 Feb 15; 59(4):807-10. PubMed ID: 10029067
    [Abstract] [Full Text] [Related]

  • 3. GPC4, the gene for human K-glypican, flanks GPC3 on xq26: deletion of the GPC3-GPC4 gene cluster in one family with Simpson-Golabi-Behmel syndrome.
    Veugelers M, Vermeesch J, Watanabe K, Yamaguchi Y, Marynen P, David G.
    Genomics; 1998 Oct 01; 53(1):1-11. PubMed ID: 9787072
    [Abstract] [Full Text] [Related]

  • 4. Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma.
    Murthy SS, Shen T, De Rienzo A, Lee WC, Ferriola PC, Jhanwar SC, Mossman BT, Filmus J, Testa JR.
    Oncogene; 2000 Jan 20; 19(3):410-6. PubMed ID: 10656689
    [Abstract] [Full Text] [Related]

  • 5. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J, Luo RZ, Fujii S, Wang L, Hu W, Andreeff M, Pan Y, Kadota M, Oshimura M, Sahin AA, Issa JP, Bast RC, Yu Y.
    Cancer Res; 2003 Jul 15; 63(14):4174-80. PubMed ID: 12874023
    [Abstract] [Full Text] [Related]

  • 6. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome.
    Pilia G, Hughes-Benzie RM, MacKenzie A, Baybayan P, Chen EY, Huber R, Neri G, Cao A, Forabosco A, Schlessinger D.
    Nat Genet; 1996 Mar 15; 12(3):241-7. PubMed ID: 8589713
    [Abstract] [Full Text] [Related]

  • 7. Overgrowth of a mouse model of the Simpson-Golabi-Behmel syndrome is independent of IGF signaling.
    Chiao E, Fisher P, Crisponi L, Deiana M, Dragatsis I, Schlessinger D, Pilia G, Efstratiadis A.
    Dev Biol; 2002 Mar 01; 243(1):185-206. PubMed ID: 11846487
    [Abstract] [Full Text] [Related]

  • 8. Promoter hypermethylation of DLC-1, a candidate tumor suppressor gene, in several common human cancers.
    Yuan BZ, Durkin ME, Popescu NC.
    Cancer Genet Cytogenet; 2003 Jan 15; 140(2):113-7. PubMed ID: 12645648
    [Abstract] [Full Text] [Related]

  • 9. OCI-5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line-specific manner.
    Gonzalez AD, Kaya M, Shi W, Song H, Testa JR, Penn LZ, Filmus J.
    J Cell Biol; 1998 Jun 15; 141(6):1407-14. PubMed ID: 9628896
    [Abstract] [Full Text] [Related]

  • 10. Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer.
    Kuroki T, Trapasso F, Yendamuri S, Matsuyama A, Alder H, Williams NN, Kaiser LR, Croce CM.
    Cancer Res; 2003 Jun 15; 63(12):3352-5. PubMed ID: 12810670
    [Abstract] [Full Text] [Related]

  • 11. Growth promotion of HepG2 hepatoma cells by antisense-mediated knockdown of glypican-3 is independent of insulin-like growth factor 2 signaling.
    Sung YK, Hwang SY, Farooq M, Kim JC, Kim MK.
    Exp Mol Med; 2003 Aug 31; 35(4):257-62. PubMed ID: 14508064
    [Abstract] [Full Text] [Related]

  • 12. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.
    Hui AB, Lo KW, Kwong J, Lam EC, Chan SY, Chow LS, Chan AS, Teo PM, Huang DP.
    Mol Carcinog; 2003 Dec 31; 38(4):170-8. PubMed ID: 14639656
    [Abstract] [Full Text] [Related]

  • 13. The heparan sulfate proteoglycan GPC3 is a potential lung tumor suppressor.
    Kim H, Xu GL, Borczuk AC, Busch S, Filmus J, Capurro M, Brody JS, Lange J, D'Armiento JM, Rothman PB, Powell CA.
    Am J Respir Cell Mol Biol; 2003 Dec 31; 29(6):694-701. PubMed ID: 12816733
    [Abstract] [Full Text] [Related]

  • 14. Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling.
    Capurro MI, Xiang YY, Lobe C, Filmus J.
    Cancer Res; 2005 Jul 15; 65(14):6245-54. PubMed ID: 16024626
    [Abstract] [Full Text] [Related]

  • 15. Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas.
    Zhong S, Tang MW, Yeo W, Liu C, Lo YM, Johnson PJ.
    Clin Cancer Res; 2002 Apr 15; 8(4):1087-92. PubMed ID: 11948118
    [Abstract] [Full Text] [Related]

  • 16. Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 gene.
    Veugelers M, Cat BD, Muyldermans SY, Reekmans G, Delande N, Frints S, Legius E, Fryns JP, Schrander-Stumpel C, Weidle B, Magdalena N, David G.
    Hum Mol Genet; 2000 May 22; 9(9):1321-8. PubMed ID: 10814714
    [Abstract] [Full Text] [Related]

  • 17. A small interstitial deletion in the GPC3 gene causes Simpson-Golabi-Behmel syndrome in a Dutch-Canadian family.
    Xuan JY, Hughes-Benzie RM, MacKenzie AE.
    J Med Genet; 1999 Jan 22; 36(1):57-8. PubMed ID: 9950367
    [Abstract] [Full Text] [Related]

  • 18. Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation.
    Zhang F, Wu LM, Zhou L, Chen QX, Xie HY, Feng XW, Zheng SS.
    Ann Surg Oncol; 2008 Dec 22; 15(12):3494-502. PubMed ID: 18830757
    [Abstract] [Full Text] [Related]

  • 19. Oncogenic activation of glypican-3 by c-Myc in human hepatocellular carcinoma.
    Li L, Jin R, Zhang X, Lv F, Liu L, Liu D, Liu K, Li N, Chen D.
    Hepatology; 2012 Oct 22; 56(4):1380-90. PubMed ID: 22706665
    [Abstract] [Full Text] [Related]

  • 20. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
    Gupta A, Godwin AK, Vanderveer L, Lu A, Liu J.
    Cancer Res; 2003 Feb 01; 63(3):664-73. PubMed ID: 12566312
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.